Literature DB >> 18216315

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.

Tamara Isakova1, Orlando Gutierrez, Anand Shah, Lorraine Castaldo, Julie Holmes, Hang Lee, Myles Wolf.   

Abstract

Normophosphatemia and normocalcemia are maintained in chronic kidney disease (CKD) by increased levels of fibroblast growth factor-23 (FGF-23) and parathyroid hormone (PTH), but the stimuli for secretion of these hormones in early CKD are incompletely understood. Most human physiologic studies have focused on random or fasting measurements of phosphorus, calcium, FGF-23, and PTH, but in this study, the hypothesis was that measurements in the postprandial state may reveal intermittent stimuli that lead to increased FGF-23 and PTH levels. The 4-h postprandial response in 13 patients with CKD and fasting normophosphatemia and normocalcemia (mean GFR 41 +/- 8 ml/min per m(2)) was compared with 21 healthy volunteers. Compared with healthy subjects, fasting patients with CKD had significantly higher levels of FGF-23 and fractional excretion of phosphorus; lower fractional excretion of calcium; and no difference in serum calcium, phosphorus, and PTH levels. After standardized meals, urinary phosphorus excretion in both groups increased despite unchanged serum phosphorus and FGF-23 levels. Postprandial urinary calcium excretion also increased in both groups, and this was accompanied by significantly reduced serum calcium and increased PTH levels in patients with CKD only; therefore, FGF-23 does not seem to be an acute postprandial regulator of phosphaturia in CKD or in health, but inappropriate postprandial calciuria with episodic, relative hypocalcemia may represent a previously unreported mechanism of secondary hyperparathyroidism in CKD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216315      PMCID: PMC2391049          DOI: 10.1681/ASN.2007060673

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  42 in total

Review 1.  Potential mechanisms mediating postprandial renal hyperemia and hyperfiltration.

Authors:  A J Premen
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

Review 2.  On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

Authors:  N S Bricker
Journal:  N Engl J Med       Date:  1972-05-18       Impact factor: 91.245

3.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

4.  Hypovitaminosis D in medical inpatients.

Authors:  M K Thomas; D M Lloyd-Jones; R I Thadhani; A C Shaw; D J Deraska; B T Kitch; E C Vamvakas; I M Dick; R L Prince; J S Finkelstein
Journal:  N Engl J Med       Date:  1998-03-19       Impact factor: 91.245

5.  Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.

Authors:  F L Coe; J M Canterbury; J J Firpo; E Reiss
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

6.  Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study.

Authors:  Esther A González; Ashutosh Sachdeva; Dana A Oliver; Kevin J Martin
Journal:  Am J Nephrol       Date:  2004-09-22       Impact factor: 3.754

7.  Calciuric response to 1,25-(OH)2D3 in early renal failure.

Authors:  B Cremer; E Lübbers; P Klooker; H Schmidt-Gayk; E Ritz
Journal:  Miner Electrolyte Metab       Date:  1985

8.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Study of calcium absorption in man: a kinetic analysis and physiologic model.

Authors:  S J Birge; W A Peck; M Berman; G D Whedon
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

10.  Comparison of vascular effects of gastrointestinal hormones on various organs.

Authors:  C C Chou; C P Hsieh; J M Dabney
Journal:  Am J Physiol       Date:  1977-02
View more
  48 in total

1.  Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Kelsey Smith; Michael Epstein; Neha Patel; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2010-06-07       Impact factor: 5.992

2.  Acute effects of plyometric jumping and intermittent running on serum bone markers in young males.

Authors:  Che-Fu Lin; Tsang-hai Huang; Kuo-Cheng Tu; Linda L Lin; Yi-Hsuan Tu; Rong-Sen Yang
Journal:  Eur J Appl Physiol       Date:  2011-08-12       Impact factor: 3.078

3.  Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

Authors:  Sharon M Moe; Miriam P Zidehsarai; Mary A Chambers; Lisa A Jackman; J Scott Radcliffe; Laurie L Trevino; Susan E Donahue; John R Asplin
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 8.237

4.  Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.

Authors:  Jason P Linefsky; Kevin D O'Brien; Ronit Katz; Ian H de Boer; Eddy Barasch; Nancy S Jenny; David S Siscovick; Bryan Kestenbaum
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

5.  Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

Authors:  Pieter Evenepoel; Björn Meijers; Liesbeth Viaene; Bert Bammens; Kathleen Claes; Dirk Kuypers; Dirk Vanderschueren; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

Review 6.  Arterial calcification and bone physiology: role of the bone-vascular axis.

Authors:  Bithika Thompson; Dwight A Towler
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

Review 7.  Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

Authors:  James B Wetmore; L Darryl Quarles
Journal:  Nat Clin Pract Nephrol       Date:  2008-10-28

8.  Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ian H de Boer; Tessa C Rue; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2008-11-06       Impact factor: 8.860

9.  Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease.

Authors:  Shunsuke Goto; Kentaro Nakai; Keiji Kono; Yuriko Yonekura; Jun Ito; Hideki Fujii; Shinichi Nishi
Journal:  Clin Exp Nephrol       Date:  2014-03-01       Impact factor: 2.801

Review 10.  The use of fibroblast growth factor 23 testing in patients with kidney disease.

Authors:  Edward R Smith
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.